Clinical observation of the effect of Xuesaitong soft capsule (Chinese characters) on post-hepatitis fibrosis

Chinese Journal of Integrative Medicine

Volumn 11, Issue 1, 2005, Pages 11-14

  Deng, Yin Quan ^a   Fan, Xiao Fen ^a   Li, You Di ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Collagen IV; Hyaluronic acid; Laminin; Post hepatitis fibrosis; Procollagen III; Xuesaitong soft capsule

Indexed keywords

CHINESE DRUG; COLLAGEN TYPE 4; HERBACEOUS AGENT; HYALURONIC ACID; LAMININ; PROCOLLAGEN; PROCOLLAGEN 3; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG; XUESAITONG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 19944370459     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02835741     Document Type: Article

References (8)

1. Zheng GZ. Biology and application of Radix Notoginseng. Beijing: Science Press. 1994: 85.
2. Hepatology Society, Chinese Medical Association. Prevention and treatment program of viral hepatitis. Chin J Hepatol 2000; (6): 324-329.
3. Specialty Committee of Internal Medicine Hepatopathy, Chinese Association of Traditional Chinese Medicine. A standard on judgment the therapeutic effects of viral hepatitis for TCM. J TCM 1992; 33(6): 373.
4. Su Y, Zhao YG, Zhang ZP. The effect of PTS to the platelet function and thrombosis in animals. Chin Tradit Herb Drugs 1996; 27(11): 666-669.
5. Wang J, Xu J, Zhong JB, et al. Effect of Radix Notoginseng Saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome. Chin J Integr Tradit West Med 2004; 24(4): 312-316.
6. Ma K, Tang JT. Progress of experimental study of Radix Notoginseng Saponins. Zhejiang J Integr Tradit West Med 2002; 12(3): 197-199.
7. Xie SB, Yao JL, Zheng SS, et al. The relationship between the levels of serum fibrosis markers and morphometric quantitative measurement of hepatic histological fibrosis. Chin J Hepatol 2000; 8(4): 203-205.
8. Chen RL, Zhang HJ, Fang CY, et al. Diagnostic value of liver fibrosis criteria and total biliary acid combined examination in the chronic hepatopathy. J Hepatol Integr Tradit West Med 2001; 11(2): 95-96.